封面
市場調查報告書
商品編碼
1763882

CRISPR 診斷市場-全球產業規模、佔有率、趨勢、機會和預測(按產品、技術、應用、最終用戶、地區和競爭細分,2020-2030 年)

CRISPR-Based Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technology, By Application, By End User, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球基於 CRISPR 的診斷市值為 31.6 億美元,預計到 2030 年將達到 81.2 億美元,預測期內的複合年成長率為 17.02%。由於對準確、經濟高效和快速的分子診斷工具的需求不斷成長,該市場正在經歷快速成長。基於 CRISPR 的診斷技術利用基因編輯機制高精度檢測 DNA 或 RNA 序列,有助於早期識別傳染病、遺傳疾病和癌症。這些工具在即時檢測、個人化醫療和伴隨診斷的應用日益廣泛,正在加速市場採用。不斷擴大的研究投資、生物技術公司與學術機構之間的合作以及向分散檢測的轉變進一步推動了成長。這些診斷技術只需極少的樣品製備即可提供結果,並且不需要先進的實驗室基礎設施,非常適合臨床和遠端環境。

市場概覽
預測期 2026-2030
2024年市場規模 31.6億美元
2030年市場規模 81.2億美元
2025-2030 年複合年成長率 17.02%
成長最快的領域 癌症診斷
最大的市場 北美洲

關鍵市場促進因素

CRISPR技術和平台開發的進展

主要市場挑戰

有限的臨床驗證和標準化

主要市場趨勢

擴展即時護理和居家檢測應用

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球基於 CRISPR 的診斷市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依產品(酵素、試劑盒和試劑、軟體和庫)
    • 按技術(Cas9、Cas12、其他)
    • 按應用(傳染病診斷、遺傳疾病診斷、癌症診斷、其他)
    • 按最終用戶(醫院和診所診斷、實驗室、製藥和生物技術公司等)
    • 按公司分類(2024)
    • 按地區
  • 市場地圖

第6章:北美基於 CRISPR 的診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章:歐洲基於 CRISPR 的診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太地區 CRISPR 診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章:南美CRISPR診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東和非洲 CRISPR 診斷市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 合併與收購(如有)
  • 產品發布(如有)
  • 最新動態

第13章:干擾:衝突、流行病與貿易壁壘

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章:競爭格局

  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Molbio Diagnostics
  • Horizon Discovery
  • Synthego Corporation
  • Mammoth Biosciences
  • Sherlock Biosciences
  • Caribou Biosciences
  • CrisprBits
  • ToolGen Inc.

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 29924

The Global CRISPR-Based Diagnostics Market was valued at USD 3.16 billion in 2024 and is projected to reach USD 8.12 billion by 2030, growing at a CAGR of 17.02% during the forecast period. This market is witnessing rapid growth due to rising demand for accurate, cost-efficient, and fast molecular diagnostic tools. CRISPR-based diagnostics utilize gene-editing mechanisms to detect DNA or RNA sequences with high precision, aiding early identification of infectious diseases, genetic conditions, and cancers. The increasing application of these tools in point-of-care testing, personalized medicine, and companion diagnostics is accelerating market adoption. Growth is further fueled by expanding research investments, collaborations between biotech firms and academic institutions, and a shift toward decentralized testing. These diagnostics offer results with minimal sample preparation and without the need for advanced lab infrastructure, making them well-suited for both clinical and remote environments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 3.16 Billion
Market Size 2030USD 8.12 Billion
CAGR 2025-203017.02%
Fastest Growing SegmentCancer Diagnostics
Largest MarketNorth America

Key Market Drivers

Advancements in CRISPR Technology and Platform Development

Technological progress in CRISPR systems and platform innovations is significantly contributing to market growth. Enhanced enzyme engineering has improved the specificity and efficiency of Cas variants like Cas12, Cas13, and Cas14, enabling detection of multiple biomarkers with reduced off-target effects. Developments in portable diagnostic formats-such as lateral-flow strips, paper-based assays, and microfluidic devices-have made CRISPR tools accessible and easy to use, even outside of laboratory settings. Integration with AI for guide RNA design and interpretation software has improved diagnostic accuracy and user experience. Public-sector initiatives are also fostering innovation; for example, the NIH's Somatic Cell Genome Editing (SCGE) Program allocated USD 89 million in 2024 to improve genome-editing technologies, while a USD 27 million project launched a Genomics Learning Health System Network to incorporate genomic diagnostics into routine care.

Key Market Challenges

Limited Clinical Validation and Standardization

Despite promising laboratory results, CRISPR-based diagnostics face hurdles due to limited clinical validation and lack of standardization. Large-scale, peer-reviewed clinical trials evaluating these technologies across diverse populations and biological sample types are still sparse. Many current assays lack proven efficacy in complex samples such as blood or saliva, where potential interferences can compromise accuracy. This insufficient validation presents challenges for regulatory approvals and delays adoption in clinical settings. Medical institutions require comprehensive, reproducible evidence to trust and implement new diagnostic platforms, and the current data gaps hinder wider integration into healthcare systems.

Key Market Trends

Expansion of Point-of-Care and At-Home Testing Applications

The move toward decentralized diagnostic solutions is shaping the growth trajectory of CRISPR-based diagnostics. Traditional lab-based diagnostics can be slow and require skilled personnel, but CRISPR platforms offer a quicker, simpler alternative. Innovations in lyophilized reagents, compact lateral flow systems, and microfluidic devices have paved the way for CRISPR-based tests suitable for primary care, pharmacies, and even home use. These solutions are particularly valuable in low-resource or rural settings. Growing interest in remote healthcare and instant diagnostic results-especially for infectious diseases, chronic conditions, and genetic screening-is fueling demand. Additionally, smartphone-compatible, user-operated devices are gaining popularity among consumers. Features such as disposable cartridges, refrigeration-free storage, and minimal training requirements are making CRISPR diagnostics increasingly viable for widespread, non-laboratory applications.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Molbio Diagnostics
  • Horizon Discovery
  • Synthego Corporation
  • Mammoth Biosciences
  • Sherlock Biosciences
  • Caribou Biosciences
  • CrisprBits
  • ToolGen Inc.

Report Scope:

In this report, the Global CRISPR-Based Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

CRISPR-Based Diagnostics Market, By Product:

  • Enzymes
  • Kits and Reagents
  • Software and Libraries

CRISPR-Based Diagnostics Market, By Technology:

  • Cas9
  • Cas12
  • Others

CRISPR-Based Diagnostics Market, By Application:

  • Infectious Disease Diagnostics
  • Genetic Disorder Diagnostics
  • Cancer Diagnostics
  • Others

CRISPR-Based Diagnostics Market, By End User:

  • Hospitals and Clinics Diagnostic
  • Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

CRISPR-Based Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global CRISPR-Based Diagnostics Market.

Available Customizations:

Global CRISPR-Based Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global CRISPR-Based Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Enzymes, Kits and Reagents, Software and Libraries)
    • 5.2.2. By Technology (Cas9, Cas12, Others)
    • 5.2.3. By Application (Infectious Disease Diagnostics, Genetic Disorder Diagnostics, Cancer Diagnostics, Others)
    • 5.2.4. By End User (Hospitals and Clinics Diagnostic, Laboratories, Pharmaceutical and Biotechnology Companies, Others)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America CRISPR-Based Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Technology
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States CRISPR-Based Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Technology
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Mexico CRISPR-Based Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Technology
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Canada CRISPR-Based Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Technology
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe CRISPR-Based Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Technology
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France CRISPR-Based Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. Germany CRISPR-Based Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. United Kingdom CRISPR-Based Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. Italy CRISPR-Based Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain CRISPR-Based Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific CRISPR-Based Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Technology
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China CRISPR-Based Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India CRISPR-Based Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. South Korea CRISPR-Based Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. Japan CRISPR-Based Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia CRISPR-Based Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America CRISPR-Based Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Technology
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil CRISPR-Based Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina CRISPR-Based Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia CRISPR-Based Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa CRISPR-Based Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Technology
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa CRISPR-Based Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia CRISPR-Based Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE CRISPR-Based Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Integrated DNA Technologies, Inc.
  • 15.3. Molbio Diagnostics
  • 15.4. Horizon Discovery
  • 15.5. Synthego Corporation
  • 15.6. Mammoth Biosciences
  • 15.7. Sherlock Biosciences
  • 15.8. Caribou Biosciences
  • 15.9. CrisprBits
  • 15.10. ToolGen Inc.

16. Strategic Recommendations

17. About Us & Disclaimer